Where Teladoc Health Stands With Analysts

Teladoc Health TDOC underwent analysis by 7 analysts in the last quarter, revealing a spectrum of viewpoints from bullish to bearish.

In the table below, you'll find a summary of their recent ratings, revealing the shifting sentiments over the past 30 days and comparing them to the previous months.

Bullish Somewhat Bullish Indifferent Somewhat Bearish Bearish
Total Ratings 1 3 3 0 0
Last 30D 0 0 1 0 0
1M Ago 1 3 2 0 0
2M Ago 0 0 0 0 0
3M Ago 0 0 0 0 0

Analysts have set 12-month price targets for Teladoc Health, revealing an average target of $22.43, a high estimate of $28.00, and a low estimate of $17.00. This current average represents a 17.45% decrease from the previous average price target of $27.17.

price target chart

Interpreting Analyst Ratings: A Closer Look

A comprehensive examination of how financial experts perceive Teladoc Health is derived from recent analyst actions. The following is a detailed summary of key analysts, their recent evaluations, and adjustments to ratings and price targets.

Analyst Analyst Firm Action Taken Rating Current Price Target Prior Price Target
Michael Cherny Leerink Partners Announces Market Perform $17.00 -
Gil Luria DA Davidson Lowers Neutral $18.00 $22.00
Daniel Grosslight Citigroup Lowers Neutral $19.00 $21.00
Sean Dodge RBC Capital Lowers Outperform $25.00 $30.00
Steve Valiquette Barclays Lowers Overweight $25.00 $26.00
Jessica Tassan Piper Sandler Lowers Overweight $25.00 $30.00
Richard Close Canaccord Genuity Lowers Buy $28.00 $34.00

Key Insights:

  • Action Taken: In response to dynamic market conditions and company performance, analysts update their recommendations. Whether they 'Maintain', 'Raise', or 'Lower' their stance, it signifies their reaction to recent developments related to Teladoc Health. This insight gives a snapshot of analysts' perspectives on the current state of the company.
  • Rating: Offering insights into predictions, analysts assign qualitative values, from 'Outperform' to 'Underperform'. These ratings convey expectations for the relative performance of Teladoc Health compared to the broader market.
  • Price Targets: Gaining insights, analysts provide estimates for the future value of Teladoc Health's stock. This comparison reveals trends in analysts' expectations over time.

Considering these analyst evaluations in conjunction with other financial indicators can offer a comprehensive understanding of Teladoc Health's market position. Stay informed and make well-informed decisions with our Ratings Table.

Stay up to date on Teladoc Health analyst ratings.

Discovering Teladoc Health: A Closer Look

Teladoc Health is a virtual health provider with a telehealth platform delivering 24-hour, on-demand healthcare via mobile devices, the internet, video, and phone. It also offers remote patient monitoring programs for chronic care management. Its platform connects members with a network of physicians and behavioral health professionals. Most of the company's revenue is generated from access fees on a subscription basis (per member, per month). The balance comes from visit fees and equipment rental and sales to hospital systems. Since inception, Teladoc has primarily partnered with employers, health plans, and health systems to offer network access to their members; it has also started to market directly to consumers while expanding its service portfolio.

Unraveling the Financial Story of Teladoc Health

Market Capitalization Analysis: Reflecting a smaller scale, the company's market capitalization is positioned below industry averages. This could be attributed to factors such as growth expectations or operational capacity.

Revenue Growth: Teladoc Health's remarkable performance in 3 months is evident. As of 31 December, 2023, the company achieved an impressive revenue growth rate of 0.04%. This signifies a substantial increase in the company's top-line earnings. In comparison to its industry peers, the company trails behind with a growth rate lower than the average among peers in the Health Care sector.

Net Margin: Teladoc Health's net margin is impressive, surpassing industry averages. With a net margin of -4.37%, the company demonstrates strong profitability and effective cost management.

Return on Equity (ROE): Teladoc Health's ROE excels beyond industry benchmarks, reaching -1.25%. This signifies robust financial management and efficient use of shareholder equity capital.

Return on Assets (ROA): Teladoc Health's ROA stands out, surpassing industry averages. With an impressive ROA of -0.66%, the company demonstrates effective utilization of assets and strong financial performance.

Debt Management: Teladoc Health's debt-to-equity ratio is below industry norms, indicating a sound financial structure with a ratio of 0.68.

The Basics of Analyst Ratings

Ratings come from analysts, or specialists within banking and financial systems that report for specific stocks or defined sectors (typically once per quarter for each stock). Analysts usually derive their information from company conference calls and meetings, financial statements, and conversations with important insiders to reach their decisions.

Some analysts publish their predictions for metrics such as growth estimates, earnings, and revenue to provide additional guidance with their ratings. When using analyst ratings, it is important to keep in mind that stock and sector analysts are also human and are only offering their opinions to investors.

This article was generated by Benzinga's automated content engine and reviewed by an editor.

Market News and Data brought to you by Benzinga APIs
Comments
Loading...
date
▲▼
ticker
▲▼
name
▲▼
Price Target
▲▼
Upside/Downside
▲▼
Recommendation
▲▼
Firm
▲▼
Posted In: Analyst RatingsBZI-AAR
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!